| |
Israel Connect
Legal Insight for Success in the US Market
INAUGURAL ISSUE — Rosh Hashanah 2015
Welcome to Israel Connect, a newsletter providing tips and information to help your Israeli company thrive in the US marketplace. Here you will find news about US laws and regulations impacting Israeli businesses; highlights from Mintz Levin blogs addressing legal developments in technology, life sciences, health care, energy, medical device, and other key industries; and notices of upcoming events where you can hear from and meet attorneys from our accomplished legal team.
Mintz Levin has more than 15 years of experience working in Israel and serves more than 200 Israeli clients. Highly ranked and recognized by Chambers Global, our Israel Practice includes a multidisciplinary group of lawyers – including US-based Israeli attorneys – who know your political and business culture as well as Israel’s legal and regulatory landscape. We are here to respond to your needs. For assistance, please contact Karen Sealine in Tel Aviv at 972.54.4706614.
Shanah Tovah,
Adam
|
We are thrilled to spotlight Splacer Inc. – the Israeli winner of Qualcomm’s QPrize – in this inaugural issue of our newsletter. Currently operating in Israel and in beta in the New York City market, Splacer connects companies with unique, creative spaces for short-term events, offsite meetings, photo shoots, and workshops.
|
|
|
|
Our congratulations go out as well to our client FeeX, which was recently selected by WIRED magazine as one of the 10 hottest Israeli start-ups. FeeX helps clients reduce fees on their retirement funds to boost their savings. Read the WIRED article at the link below.
|
|
|
Return to top
|
Israeli companies and individuals have recently come under the scrutiny of US regulators investigating possible violations of the US Foreign Corrupt Practices Act (FCPA). The investigations have touched upon several key sectors of the Israeli economy, including technology, energy, defense, health care, life sciences, and mining. In at least one instance, significant penalties have been assessed.
This article explains what the FCPA is and outlines what Israeli companies and individuals can do to avoid investigations and liability.
|
|
|
|
The US Supreme Court’s recent decision in Commil v. Cisco held that a good-faith belief of a patent’s invalidity, standing alone, is insufficient to provide a defense to a claim of inducing another’s infringement of a US Patent.
This article examines the reasoning behind this landmark ruling as well as its potential impact.
|
|
|
Return to top
Mintz Levin's attorneys blog on a broad range of legal issues affecting Israeli and international businesses. In this issue of our newsletter, we feature two blog posts by Dionne Lomax from our Antitrust Practice.
|
According to US Federal Trade Commission (FTC) Chairwoman Edith Ramirez, the health care sector will “remain a top agency priority.” Thus, the FTC will undoubtedly continue to closely analyze combinations of providers in the industry. Extensive time, money, and planning are often involved when developing and consummating transactions with competitors.
|
|
|
|
The health care industry remains an enforcement priority for the US Federal Trade Commission (FTC). In a recent interview, the Director of the FTC's Bureau of Competition, Debbie Feinstein, outlined the Bureau's top three priorities for health care antitrust enforcement.
|
|
|
Return to top
|
A Review of the US Supreme Court and Federal Circuit IP and the Effects on Doing Business in the Era of Data Privacy and Cybersecurity
September 9, 2015
16.30 - 19.00
Gross, Kleinhendler, Hodak, Halevy, Greenberg & Co., Tel Aviv
Adam Samansky
How do data privacy concerns and US patent law decisions affect your business? Join us as we review recent developments and discuss how these issues will affect your patent strategy.
If you would like to meet Adam, click here.
|
|
October 14, 2015
9:00 – 11:30
Crowne Plaza Tel Aviv City Center, Tel Aviv
Ran Zioni and Marc Mantell
All technology companies will consider an exit strategy at some point in their life cycle. But what happens when you pursue two exit strategies – being acquired and conducting an initial public offering – at the same time? This panel, including technology leaders who have successfully used this strategy in their own businesses, will provide you with the insights and practical tips necessary to build and enhance value through a dual-track M&A and IPO pathway.
If you would like to meet Ran and Marc, click here.
|
|
|
Mintz Levin includes more than 500 attorneys serving clients worldwide. The lawyers in our Israel Practice bring deep experience in Israeli industries to help your business connect in the US and global markets.
Adam Sisitsky
Chair, Israel Practice
Adam focuses on business and securities litigation, internal investigations, and US government enforcement actions. He represents clients in SEC investigations and enforcement proceedings as well as in civil litigation. Adam routinely counsels public and private companies and others in matters involving compliance issues, including matters arising under the US Foreign Corrupt Practices Act (FCPA). Read more.
Tom Burton
Chair, Energy Technology Practice
Tom founded and chairs the firm’s Energy Technology Practice, which has completed more than 350 transactions totaling over $7 billion. He is ranked by Best Lawyers in America in the Corporate Law section and recognized by The Legal 500 United States as “rising to the fore” in energy technology for Venture Capital and Emerging Companies. Read more.
Bill Geary
Member
Bill is an experienced patent and trademark attorney with a particular background in medical technology, polymers and advanced materials, and chemicals. He is recognized in Chambers USA (Massachusetts — Intellectual Property) and was recognized for 10 consecutive years in Massachusetts Super Lawyers. For the past two years, he has also been named an IP Star by Managing Intellectual Property.
Read more.
Adam Samansky
Member
Adam’s practice focuses on IP litigation. His core practice includes patent and trade secret litigation involving complex technologies in the pharmaceutical, medical, high-tech, and defense industries. Adam has tried cases before multiple US District Courts, briefed and argued cases before the US Court of Appeals for the Federal Circuit, and briefed bet-the-company issues before the US Supreme Court. Read more.
Susan Berson
Managing Member, DC office
Susan has advised some of the largest government health programs and negotiated some of the largest pharmacy service agreements in the United States. She has been listed in Chambers USA for three consecutive years and is recognized by The Legal 500 United States. Susan is also a recipient of the International Law Office and Lexology’s Client Choice Award for Healthcare & Life Sciences.
Read more.
Ran Zioni
International Member
Ran represents companies in mergers and acquisitions, venture capital, and private equity financing transactions as well as in technology licensing and outsourcing transactions. In addition to his work with Israeli companies, Ran advises US clients on matters involving Israeli law and on issues relevant to US participants in Israel’s venture capital and high-tech industries. Read more.
Merav Gershtenman, 212.692.6806
Associate
Merav represents issuers and underwriters in capital market transactions, including IPOs, follow-on offerings, PIPEs, and At-the-Market offerings. Merav also concentrates her practice on providing, on an ongoing basis, counsel to public companies with respect to compliance and disclosure obligations under the securities laws, corporate governance matters, listing and compliance with various trading markets, including NYSE, NASDAQ, and OTC markets. Read more.
Karen Sealine, 972.54.4706614
|
|
